Risky Science: Is Anybody Watching The Experimental AIDS Mouse?

When research is mobilized around combating a virulent infectious agent, risk-taking is inevitable. That has been true in the pursuit of a polio vaccine and a cure for smallpox, in the study of cancer-causing viruses, and most recently, in AIDS research. While the responsible course of action is to limit as much as possible the risks to investigators and laboratory technicians, those goals can only be accomplished within certain limits. Infectious organisms are opportunistic, always seeking n

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

While the responsible course of action is to limit as much as possible the risks to investigators and laboratory technicians, those goals can only be accomplished within certain limits. Infectious organisms are opportunistic, always seeking new hosts and hew pathways to old hosts. Even under the highest biological containment conditions, laboratory workers have been infected with their experimental agents. While the risks of working with laboratory pathogens cannot be eliminated, strict guidelines, health monitoring, improved facilities, and constant vigilance have proven effective in reducing the incidence of laboratory infections.

Beyond the risk of laboratory induced infections, working with some organisms poses a risk that the agents will be released into the environment, possibly in new forms or through new routes of infection. Thus, there are ethical questions raised when experimenting with highly infectious and virulent agents. Is it appropriate to carry out experiments that may increase the host range of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Sheldon Krimsky

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio